WILLIAM F. RENCHER, Ph.D., R.Ph.
Director, Product Development, CONRAD
Assistant Professor, Dept. of Obstetrics and Gynecology, EVMS
(703) 276-3906
brencher@conrad.org
Dr. Rencher joined CONRAD in 1997. He provides expertise and leadership in product development of microbicide and contraceptive drugs and devices under development by CONRAD or our collaborators. He and his staff facilitate development of time efficient plans and their implementation by working closely with investigators, industrial partners, subcontractors and FDA. His group coordinates technology transfer, analytical method, drug synthesis and formulation development, clinical supply production and toxicology studies. He reviews and if necessary writes the CMC and Pharm/Tox sections of regulatory documents. As a member of CONRAD's Pre-Clinical Team, he solicits and reviews potential microbicides and contraceptive candidates. He is the project manager for the development of cellulose sulfate, now in Phase III clinical studies, and technical monitor for several other drug candidates with microbicidal and contraceptive properties. Dr. Rencher received his B.S. in Pharmacy in 1982 and his Ph.D. in Pharmaceutical Sciences in 1987 from the University of Kentucky. Dr. Rencher has over ten years of industry experience in the areas of drug development, bioavailability testing, project management, and development of laboratory and Good Manufacturing Practice (GMP)-compliant facilities. He is well versed in cGMP regulations and has co-written seveal Investigational New Drug applications, New Drug Applications, and Investigational Device Exemptions. He has been a co-author for journal articles on preclinical evaluation of microbicides and contraceptives and served as editor for Vaginal Microbicides Formulations Workshop, proceedings from the meeting he organized.
